双能CT定量肝脏细胞外容积分数用于排除肝硬化高危食管静脉曲张
回顾性分析229例肝硬化患者(训练组159例、内部验证组70例),采用双源双能CT延迟3分钟平衡期100/140 Sn kVp碘图测量肝脏细胞外容积分数(fECV)评分,并与CT影像联合血小板计数制定标准以排除高危食管静脉曲张(HRV)。fECV评分联合血小板计数标准排除HRV效能显著优于CT影像联合血小板计数(p<0.001),训练组和验证组分别可安全避免额外10.7%和8.6%的内镜检查,最终避免内镜比例达36.5%和35.7%(均未遗漏HRV)。
要点
- fECV评分联合血小板计数排除HRV的效能显著优于CT影像联合血小板计数(p<0.001)。
- 应用fECV评分标准在训练组和验证组分别安全避免额外10.7%和8.6%的内镜检查。
- 最终避免内镜比例训练组36.5%、验证组35.7%,均未遗漏高危食管静脉曲张。
核心结论
- 基于双能CT的fECV评分联合血小板计数有助于排除高危食管静脉曲张,较CT影像联合血小板计数可安全避免更多内镜检查。
研究设计与样本
- 回顾性分析229例肝硬化患者,训练组159例、内部验证组70例,均接受双源双能CT、血清标志物评估和食管胃十二指肠镜(EGD)检查,时间范围为2017年至2020年。
关键影像表现/征象
- fECV评分通过3分钟延迟平衡期100/140 Sn kVp碘图测量。
- 训练组中fECV评分(OR 1.20;95%CI 1.09,1.32)和CT影像(OR 28.21;95%CI 9.31,85.93)为HRV的独立预测因素。
- 血小板计数亦为独立预测因素(OR分别为0.85和0.78)。
诊断标准与关键数值
- fECV评分阈值≤25.1%联合血小板计数>150,000/mm3用于排除HRV。
- 训练组中fECV评分联合血小板计数标准排除HRV的效能显著优于CT影像联合血小板计数(p<0.001)。
- 应用该标准训练组和验证组分别安全避免额外10.7%和8.6%的EGD,最终避免EGD比例分别为36.5%和35.7%,均未遗漏HRV。
临床应用与阅片要点
- 采用双能CT延迟3分钟平衡期碘图测量fECV评分,联合血小板计数>150,000/mm3可用于排除HRV。
- 该联合标准较CT影像联合血小板计数可安全减少更多不必要的内镜检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine the performance of quantification of liver extracellular volume fraction (fECV) using dual-energy CT (DECT) compared with CT imaging for ruling out high-riskesophageal varices(HRV) in cirrhotic patients.
METHODS: We retrospectively analyzed 229 cirrhotic patients (training [n = 159] and internal validation cohorts [n = 70]) who underwent dual-source DECT, serum marker assessment, and esophagogastroduodenoscopy (EGD) from 2017 to 2020. The fECV score was measured using iodine maps from 3-minute delayed, equilibrium-phase images at 100/140 Sn kVp. The association of CT parameters and serum markers with HRV was investigated. Criteria combining the fECV score (≤ 25.1%) or CT imaging with platelet count (> 150,000/mm3) were created and compared to rule out HRV.
RESULTS: In the training cohort, the fECV score (odds ratio (OR), 1.20; 95% confidence interval (CI), 1.09, 1.32) and CT imaging (OR, 28.21; 95% CI, 9.31, 85.93) were independent predictors of HRV, along with platelet count (OR, 0.85 and 0.78). Criteria combining the fECV score with platelet count showed significantly better performance than those combining CT imaging with platelet count in ruling out HRV (p < 0.001). Applying the criteria could have safely avoided an additional 10.7% and 8.6% of EGDs in the training and validation cohorts, respectively, achieving a final value of 36.5% and 35.7% spared EGDs (0 HRV missed) compared to CT imaging with platelet count.
CONCLUSIONS: The combined DECT-based fECV score with platelet count is useful for ruling out HRV and can safely avoid more EGDs than CT imaging with platelet count.
引用
- Hong, Kim, Cho, et al. Quantification of liver extracellular volume using dual-energy CT for ruling out high-risk varices in cirrhosis. Eur J Radiol. 2022. PMID: 35032849. doi:10.1016/j.ejrad.2022.110151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。